PAN Foundation Patient Assistance Grants

Prostate Cancer Copay Grant is a financial assistance grant from the Patient Access Network (PAN) Foundation that helps eligible patients afford out-of-pocket costs for covered prescription medications used to treat prostate cancer. Awards of up to $5,000 per year are available to patients being treated for prostate cancer who reside and receive treatment in the United States. Patients must have health insurance and provide diagnosis verification, medication information, provider details, and income documentation. If a fund is open, patients may apply for additional funding within the same 12-month eligibility period. In March 2026, the PAN Foundation and Patient Advocate Foundation announced a strategic merger.

Rare Belonging® Grant Program is sponsored by Alexion Charitable Foundation. The Alexion Charitable Foundation's Rare Belonging® grant program supports programs and services that benefit individuals, caregivers, and families impacted by rare diseases, aligning with its mission to address health disparities within and among the rare disease community. Priorities include science-driven solutions, technology and innovation, patient supports, and research & policy focused on diagnostic pathways and systems improvements. The program specifically seeks to advance emotional well-being and educational opportunities, and provide relief for critical needs, especially for those living with or affected by a rare disease.

PCORI Cycle 2 2026 Methods Funding Announcement specifically prioritizes Methods to Improve the Use of Artificial Intelligence (AI) and Machine Learning (ML) in Patient-Centered Comparative Effectiveness Research (CER). The program funds studies addressing high-impact methodological gaps, with AI/ML topics including applications of AI/ML to augment or transform research methodologies or processes and approaches using AI/ML to enhance health communication. Additional priority areas include Methods to Support Use of Real-World Data in Multi-Site Patient-Centered CER and Methods to Improve Study Design. Awards provide up to $750,000 in direct costs for up to 3 years from a total program budget of $12 million. Applicants must address PCORI Foundational Expectations for Partnerships in Research, ensuring patients and stakeholders meaningfully contribute lived experience. Letter of Intent deadline is April 28, 2026, with full applications due September 1, 2026.